Skip to main content
. 2023 Aug 30;14:789–806. doi: 10.18632/oncotarget.28490

Table 3. Overall performance of NeXT Dx.

Variant Specification
Analytic Sensitivity Single Nucleotide Variants, AF≥5% 99.4% (CI 99.0–99.6%)
Analytic Sensitivity Insertions/Deletions, AF≥5% 98.2% (CI 96.9–99.1%)
Analytic Sensitivity Copy Number Alterations 98.0% (CI 93.0–99.8%)
Analytic Sensitivity Gene Fusions 95.8% (CI 90.5–98.6%)
Analytic Specificity (PPV) Specificity >99%
MSI 117 Gene Loci >99.1% Concordance
TMB Exome Wide 0.985 Pearson correlation coefficient